Skip to main content
European Commission logo print header

Validation of single and multiple mice models for alzheimer's disease.

Obiettivo

The experimental approach and different levels of analysis is aimed at understanding the molecular and cellular early phases of the neurodegeneration in Alzheimer's disease. This is not possible in humans and requires animal models that allow invasive analysis. Transgenic mice expressing human AD related genes (APP, PS1, Ape) have been and continue to be generated and will be validated. They will extend and recapitulate new findings in less complex systems, implemented in this proposal. "Multiple" transgenic mouse strains with more than one human transgenic are expected to show more complete pathology. Most important aspect addressed will be fundamental aspects of amyloidogenesis relating to the role of Personalise and its path physiological sequels on cognition, behaviour, neuropathology, oxidative stress, calcium homeostasis, protein degradation and modifying proteins.

Invito a presentare proposte

Data not available

Meccanismo di finanziamento

CSC - Cost-sharing contracts

Coordinatore

KATHOLIEKE UNIVERSITEIT LEUVEN
Contributo UE
Nessun dato
Indirizzo
Oude Markt 13
3000 LOUVAIN / LEUVEN
Belgio

Mostra sulla mappa

Costo totale
Nessun dato

Partecipanti (3)